State Street Corp Buys 2,782 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

State Street Corp lifted its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 0.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 435,164 shares of the company’s stock after acquiring an additional 2,782 shares during the period. State Street Corp owned 2.28% of USANA Health Sciences worth $16,501,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Safe Harbor Fiduciary LLC bought a new position in shares of USANA Health Sciences in the third quarter valued at approximately $30,000. KBC Group NV boosted its holdings in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the period. Centiva Capital LP acquired a new position in USANA Health Sciences in the 3rd quarter valued at $213,000. BOKF NA raised its holdings in USANA Health Sciences by 99.4% in the 2nd quarter. BOKF NA now owns 5,526 shares of the company’s stock worth $250,000 after acquiring an additional 2,755 shares during the period. Finally, Quest Partners LLC acquired a new position in USANA Health Sciences during the 3rd quarter worth $250,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

USNA has been the topic of several research analyst reports. DA Davidson raised USANA Health Sciences to a “hold” rating in a research report on Friday, December 20th. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Thursday, December 19th.

Insiders Place Their Bets

In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Price Performance

NYSE:USNA opened at $36.66 on Wednesday. USANA Health Sciences, Inc. has a one year low of $31.44 and a one year high of $54.81. The company has a fifty day moving average price of $37.89 and a 200 day moving average price of $40.07. The stock has a market cap of $698.74 million, a P/E ratio of 12.95, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the prior year, the business earned $0.59 earnings per share. As a group, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.